The company intends to use the funds to advance ENV-294 and ENV-308 into later-stage trials and additional indications, advance ENV-6946 through mid-phase trials, bring additional medicines into clinical trials for inflammatory and metabolic conditions, and scale PRISM and the automated laboratory that feeds it.

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

5700 Flatiron Parkway
Boulder, CO 80301
USA

Phone

Undisclosed

Website

www.enveda.com

Email Address

Not Recorded

Overview

Our work is a group effort. We've built a stellar team and already come a long way. Join us on the journey. We invest in learn-it-alls, not know-it-alls -- people who love the process, are obsessed with their craft, and enjoy building with other like-minded people each day. If you're a self-starter seeking new challenges in a supportive and collaborative environment, we encourage you to apply.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Viswa Colluru

Chief Marketing Officer

José Trevejo

Chief Technical Officer

August Allen

Vice President

PK Jadhav

VP - Administration

Daniel Wee

VP - Bus. Development

Bigyan Bista

VP - Bus. Development

Soumoditya Dey

VP - Bus. Development

Niranjan Rao

VP - General Counsel

Jason Tejani

VP - Human Resources

Robert Buckley

VP - Operations

Eswar Bonangi

VP - Operations

Inhwan Kim

VP - Product Management

Hannah Gordon

Browse more venture capital transactions:

Prev: 9/23/2026: Velentium Medical venture capital transaction
Next: 9/23/2026: Basecamp Research venture capital transaction

Share this article

About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary